Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_assertion type Assertion NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_head.
- NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_assertion description "[The general lack of GR in adenocarcinomas contrasts with the high percentage of SCCs and HCCs expressing GR, and, along with the generation of chemoresistance by DEX, warrants prospective study of the effects of steroids on these cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_provenance.
- NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_assertion evidence source_evidence_literature NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_provenance.
- NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_assertion SIO_000772 18269582 NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_provenance.
- NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_assertion wasDerivedFrom befree-20150227 NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_provenance.
- NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_assertion wasGeneratedBy ECO_0000203 NP434686.RA9Fl-O-BgRK8pzgq20EsKflVk6pabLY9ieL2IkMTQJKM130_provenance.